353 related articles for article (PubMed ID: 29519741)
1. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
Kumar B; Strouse J; Swee M; Lenert P; Suneja M
Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
[TBL] [Abstract][Full Text] [Related]
2. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
Dobre M; Wish J; Negrea L
Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644
[TBL] [Abstract][Full Text] [Related]
3. Overlapping drug-induced vasculitis, ANCA-associated vasculitis, and lupus nephritis caused by low-dose hydralazine.
Bhatnagar M; Agaronov A; Sarkisyan E; Sotoudeh Deilamy I; Pepito D; Akhondi H
Int J Rheum Dis; 2023 Nov; 26(11):2272-2277. PubMed ID: 37452463
[TBL] [Abstract][Full Text] [Related]
4. Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation.
Tu W; Fayman B; Ward SC; Mamoon Y; Bandagi SS
Am J Case Rep; 2021 May; 22():e931263. PubMed ID: 33993184
[TBL] [Abstract][Full Text] [Related]
5. Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection.
Rasla S; El Meligy A; Cucu DF
R I Med J (2013); 2016 Nov; 99(11):41-43. PubMed ID: 27801920
[TBL] [Abstract][Full Text] [Related]
6. Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis.
Zuckerman R; Patel M; Costanzo EJ; Dounis H; Haj RA; Seyedali S; Asif A
J Bras Nefrol; 2018; 40(2):193-197. PubMed ID: 29738027
[TBL] [Abstract][Full Text] [Related]
7. Hydralazine associated pauci-immune glomerulonephritis.
Suneja M; Baiswar S; Vogelgesang SA
J Clin Rheumatol; 2014 Mar; 20(2):99-102. PubMed ID: 24561415
[TBL] [Abstract][Full Text] [Related]
8. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.
Choi HK; Merkel PA; Walker AM; Niles JL
Arthritis Rheum; 2000 Feb; 43(2):405-13. PubMed ID: 10693882
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis.
Cambridge G; Wallace H; Bernstein RM; Leaker B
Br J Rheumatol; 1994 Feb; 33(2):109-14. PubMed ID: 8162472
[TBL] [Abstract][Full Text] [Related]
10. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
Santoriello D; Bomback AS; Kudose S; Batal I; Stokes MB; Canetta PA; Radhakrishnan J; Appel GB; D'Agati VD; Markowitz GS
Kidney Int; 2021 Aug; 100(2):440-446. PubMed ID: 33857570
[TBL] [Abstract][Full Text] [Related]
11. P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy.
Norris JH; Leeds J; Jeffrey RF
Ren Fail; 2003 Mar; 25(2):311-4. PubMed ID: 12739838
[TBL] [Abstract][Full Text] [Related]
12. Fulminant Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis After 10 Years of Hydralazine Use.
Russe-Russe JR; Pellegrini JR; Alvarez-Betancourt A; Munshi RF; Anand P
Cureus; 2021 Oct; 13(10):e18974. PubMed ID: 34820229
[TBL] [Abstract][Full Text] [Related]
13. Something Out of Nothing: A Rare Case of Pulmonary Renal Syndrome With Pauci-Immune Glomerulonephritis and Diffuse Alveolar Hemorrhage With Negative Serologies.
Wang LJ; Collazo-Maldonado R
Cureus; 2021 Oct; 13(10):e18614. PubMed ID: 34765369
[TBL] [Abstract][Full Text] [Related]
14. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage.
Xue A; Bernard A; Moreno V; Phillips L; Raff E
Cureus; 2023 Oct; 15(10):e47591. PubMed ID: 38022102
[TBL] [Abstract][Full Text] [Related]
15. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.
Short AK; Lockwood CM
QJM; 1995 Nov; 88(11):775-83. PubMed ID: 8542262
[TBL] [Abstract][Full Text] [Related]
16. Acute interstitial nephritis caused by ANCA-associated vasculitis: a case based review.
Muhammad A; Xiao Z; Lin W; Zhang Y; Meng T; Ning J; Xu H; Tang R; Xiao X
Clin Rheumatol; 2024 Mar; 43(3):1227-1244. PubMed ID: 37932622
[TBL] [Abstract][Full Text] [Related]
17. Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis.
Yokogawa N; Vivino FB
Mod Rheumatol; 2009; 19(3):338-47. PubMed ID: 19424772
[TBL] [Abstract][Full Text] [Related]
18. Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
Marina VP; Malhotra D; Kaw D
Int Urol Nephrol; 2012 Dec; 44(6):1907-9. PubMed ID: 21590349
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Hydralazine-induced Lupus.
Timlin H; Wu M; Crespo-Bosque M; Geetha D; Ingolia A; Haque U; Towns MC; Grader-Beck T
Cureus; 2019 Jun; 11(6):e4996. PubMed ID: 31497427
[TBL] [Abstract][Full Text] [Related]
20. Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report.
Al-Abdouh A; Siyal AM; Seid H; Bekele A; Garcia P
J Med Case Rep; 2020 Apr; 14(1):47. PubMed ID: 32290867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
